Cargando…

Clinical Significance of Mesenchymal Circulating Tumor Cells in Patients With Oligometastatic Hormone-Sensitive Prostate Cancer Who Underwent Cytoreductive Radical Prostatectomy

PURPOSE: Growing evidence shows that circulating tumor cells (CTCs) become more aggressive after the epithelial–mesenchymal transition (EMT), though the clinical significance of CTCs undergoing EMT in oligometastatic hormone-sensitive prostate cancer (omHSPC) patients has not yet been reported. Acco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Guanjie, Xie, Jun, Zhang, Shun, Gu, Wenyu, Yuan, Jing, Wang, Ruiliang, Guo, Changcheng, Ye, Lin, Peng, Bo, Yao, Xudong, Yang, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810514/ https://www.ncbi.nlm.nih.gov/pubmed/35127528 http://dx.doi.org/10.3389/fonc.2021.812549

Ejemplares similares

Identifying the Candidates Who Will Benefit From Extended Pelvic Lymph Node Dissection at Radical Prostatectomy Among Patients With Prostate Cancer
por: Yang, Guanjie, et al.
Publicado: (2022)

Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer
por: Chaloupka, Michael, et al.
Publicado: (2021)

The incidence of postoperative ileus in patients who underwent robotic assisted radical prostatectomy
por: Ozdemir, Ahmet Tunc, et al.
Publicado: (2014)

Predictors of well-being and quality of life in men who underwent radical prostatectomy: longitudinal study
por: Romanzini, Adilson Edson, et al.
Publicado: (2018)

Effect of preoperative PI-RADS assessment on pathological outcomes in patients who underwent radical prostatectomy
por: Peng, Qianyu, et al.
Publicado: (2023)

Primary Tumor Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Knipper, Sophie, et al.
Publicado: (2022)

Primary Tumour Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Ting, Francis, et al.
Publicado: (2022)

Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis
por: Chung, Doo Yong, et al.
Publicado: (2023)

The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score is a Novel Significant Prognostic Factor for Patients with Metastatic Prostate Cancer Undergoing Cytoreductive Radical Prostatectomy
por: Guo, Yadong, et al.
Publicado: (2019)

Calculated Tumor Volume Is an Independent Predictor of Biochemical Recurrence in Patients Who Underwent Retropubic Radical Prostatectomy
por: Tanaka, Nobumichi, et al.
Publicado: (2012)

AB056. Cytoreductive radical prostatectomy for men with oligo-metastatic prostate cancer
por: Liu, Shengjie, et al.
Publicado: (2017)

Usefulness of robot‐assisted radical prostatectomy in a patient with oligometastatic castration‐resistant prostate cancer
por: Koie, Takuya, et al.
Publicado: (2020)

Pushing the boundaries: emerging role of radical prostatectomy as part of multimodal treatment for oligometastatic prostate cancer
por: Sosnowski, Roman, et al.
Publicado: (2023)

Marital status independently predicts prostate cancer survival in men who underwent radical prostatectomy: An analysis of 95,846 individuals
por: Huang, Tian-Bao, et al.
Publicado: (2018)

Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
por: Babst, Christa, et al.
Publicado: (2022)

Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy
por: Maeda, Yoko, et al.
Publicado: (2016)

The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis
por: Cheng, Bisheng, et al.
Publicado: (2021)

Cytoreductive radical prostatectomy or radiation therapy for metastases prostate cancer: Evidence from meta-analysis
por: Peng, Zhixiong, et al.
Publicado: (2022)

Preliminary evidence of the impact of social distancing on psychological status and functional outcomes of patients who underwent robot-assisted radical prostatectomy
por: Chiancone, Francesco, et al.
Publicado: (2020)

Effects of Radiotherapy or Radical Prostatectomy on the Risk of Long-Term Heart-Specific Death in Patients With Prostate Cancer
por: Guo, Yadong, et al.
Publicado: (2020)

Morbidity and mortality in women with advanced ovarian cancer who underwent primary cytoreductive surgery compared to cytoreductive surgery for recurrent disease: a meta-analysis
por: Bartels, Helena C., et al.
Publicado: (2019)

Prognostic value of selected preoperative inflammation-based scores in patients with high-risk localized prostate cancer who underwent radical prostatectomy
por: Shu, Kunpeng, et al.
Publicado: (2018)

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
por: Yuh, Bertram E., et al.
Publicado: (2019)

Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy
por: Kim, Isaac Yi, et al.
Publicado: (2022)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma
por: Choi, Jae Young, et al.
Publicado: (2016)

Significance of Neoadjuvant Hormonal Therapy in Radical Retropubic Prostatectomy: A Retrospective Single-Surgeon Study
por: Yamamichi, Fukashi, et al.
Publicado: (2013)

Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy
por: Fujimura, Tetsuya, et al.
Publicado: (2017)

Short-term therapeutic outcomes of robotic-assisted laparoscopic radical prostatectomy for oligometastatic prostate cancer: a propensity score matching study
por: Chen, Huan, et al.
Publicado: (2020)

Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer
por: Wang, Ruiliang, et al.
Publicado: (2023)

Emerging role of cytoreductive prostatectomy in patients with metastatic disease
por: Jaber, Yasmeen, et al.
Publicado: (2018)

Predictors for lower urinary tract symptoms in patients underwent radical prostatectomy: implications for postoperative nursing care
por: Yilin, Zeng, et al.
Publicado: (2021)

Association between Seminal Vesicle Invasion and Prostate Cancer Detection Location after Transrectal Systemic Biopsy among Men Who Underwent Radical Prostatectomy
por: Lee, Young Ik, et al.
Publicado: (2016)

A Case Series of Patients Who Underwent Laparoscopic Extraperitoneal Radical Prostatectomy with the Simultaneous Implant of a Penile Prosthesis: Focus on Penile Length Preservation
por: Mondaini, Nicola, et al.
Publicado: (2018)

Blood loss during laparoscopic radical prostatectomy – is it significant or not?
por: Poletajew, Sławomir, et al.
Publicado: (2012)

Predictive factors of unfavorable prostate cancer in patients who underwent prostatectomy but eligible for active surveillance
por: Choo, Seol Ho, et al.
Publicado: (2014)

The role of cytoreductive radical prostatectomy and lymph node dissection in bone‐metastatic prostate cancer: A population‐based study
por: Zhai, Tingshuai, et al.
Publicado: (2023)

AB067. Short-term therapeutic outcomes of robotic-assisted laparoscopic radical prostatectomy (RALP) for oligometastatic prostate cancer versus non-oligometastatic prostate cancer: a propensity score matching study
por: Qu, Min, et al.
Publicado: (2018)

Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: a single centre analysis of toxicity and clinical outcome
por: Riva, Giulia, et al.
Publicado: (2017)

Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_nnb8vmlniefrabdnb6o1gvlk2t